Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “CENTESSA PHARMACEUTICALS (UK) LIMITED”

7 pharma patents match "CENTESSA PHARMACEUTICALS (UK) LIMITED" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 7
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 7 pharmaceutical patents matching "CENTESSA PHARMACEUTICALS (UK) LIMITED" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

7 results for “CENTESSA PHARMACEUTICALS (UK) LIMITED” · 30,257 patents in full index Clear search

  1. US 12421310

    CD47 binding agents

    CENTESSA PHARMACEUTICALS (UK) LIMITED · Granted Sep 23, 2025 · Expires Sep 18, 2045

    granted
  2. US 12415861

    Anti C-MET antibodies

    CENTESSA PHARMACEUTICALS (UK) LIMITED · Granted Sep 16, 2025 · Expires Sep 11, 2045

    granted
  3. US 12365672

    Compounds and their use for the treatment of alpha1-antitrypsin deficiency

    CENTESSA PHARMACEUTICALS (UK) LIMITED · Granted Jul 22, 2025 · Expires Jul 17, 2045

    granted
  4. US 12291507

    Compounds and their use for the treatment of ALPHA1-antitrypsin deficiency

    CENTESSA PHARMACEUTICALS (UK) LIMITED · Granted May 6, 2025 · Expires May 1, 2045

    granted
  5. US 12286402

    Compounds and their use for the treatment of alpha1-antitrypsin deficiency

    CENTESSA PHARMACEUTICALS (UK) LIMITED · Granted Apr 29, 2025 · Expires Apr 24, 2045

    granted
  6. US 12227580

    Antigen binding molecules that bind LIGHT

    CENTESSA PHARMACEUTICALS (UK) LIMITED · Granted Feb 18, 2025 · Expires Feb 13, 2045

    granted
  7. US 12221422

    Compounds and their use for the treatment of alpha1-antitrypsin deficiency

    CENTESSA PHARMACEUTICALS (UK) LIMITED · Granted Feb 11, 2025 · Expires Feb 6, 2045

    granted